evalu
commerci
multiplex
polymeras
chain
reaction
pcr
assay
crosssect
studi
among
adult
pediatr
case
upper
respiratori
infect
symptom
asymptomat
controlsfrom
februari
april
two
specimen
throat
swab
nasal
swab
particip
test
use
eragen
multicodeplx
respiratori
viru
panel
detect
viral
target
throat
swab
also
test
group
streptococcu
ga
pcr
respiratori
virus
detect
case
control
p
b
ga
detect
case
ga
respiratori
viru
coinfect
found
agreement
nasal
throat
swab
viral
detect
case
control
case
detect
viru
pick
throat
nasal
specimen
detect
rate
increas
combin
result
nasal
throat
swab
test
etiolog
agent
upper
respiratori
infect
uri
difficult
ascertain
base
sole
clinic
featur
viral
cultur
cumbersom
long
turnaround
time
low
yield
makela
et
al
sever
polymeras
chain
reaction
pcr
base
test
demonstr
improv
diagnost
yield
turnaround
time
compar
convent
cell
cultur
antigenbas
method
mahoni
et
al
wu
tang
eragen
multicodeplx
respiratori
viru
panel
luminex
austin
tx
usa
one
assay
coupl
multiplex
pcr
chemistri
highthroughput
microspher
flow
cytometri
simultan
detect
virus
influenza
b
respiratori
syncyti
viru
b
parainfluenza
b
metapneumoviru
adenoviru
b
c
e
coronoviru
rhinoviru
perform
characterist
test
previous
describ
nolt
et
al
report
sensit
individu
virus
rang
specif
rang
compar
viral
cultur
aren
et
al
potenti
limit
pcrbase
assay
compar
viral
cultur
increas
detect
respiratori
virus
healthi
immunocompromis
individu
absenc
respiratori
symptom
kuyper
et
al
wright
et
al
report
rate
viral
recoveri
respiratori
tract
asymptomat
individu
use
pcrbase
assay
vari
depend
popul
test
methodolog
brittainlong
et
al
buecher
et
al
graat
et
al
sato
et
al
van
gageldonklafeb
et
al
compar
inform
regard
specif
multicodeplx
system
use
symptom
refer
standard
outpati
uri
diagnosi
avail
second
case
uri
particularli
pharyngotonsil
children
group
betahemolyt
streptococcu
ga
well
establish
common
bacteri
pathogen
habl
et
al
moreov
concurr
infect
respiratori
viru
ga
identifi
prior
studi
brook
gober
van
gageldonklafeb
et
al
suggest
detect
respiratori
viru
might
preclud
antibiot
use
case
third
issu
determin
appropri
sampl
method
anatom
site
detect
respiratori
virus
use
assay
recent
studi
use
multiplex
realtim
revers
transcriptionpcr
investig
observ
increas
viral
detect
combin
differ
specimen
nasopharyng
swab
oropharyng
swab
nasopharyng
wash
adult
hospit
lower
respiratori
tract
infect
lieberman
et
al
outpati
set
nasal
throat
swab
frequent
conveni
obtain
especi
children
unknown
whether
type
specimen
nasal
versu
throat
swab
affect
viral
detect
use
multiplex
pcr
uri
primari
aim
present
studi
compar
detect
respiratori
virus
outpati
adult
children
uri
asymptomat
individu
use
eragen
multicodeplx
respiratori
viru
panel
secondari
aim
identifi
etiolog
agent
uri
among
outpati
includ
coinfect
viru
ga
compar
viral
recoveri
use
assay
throat
nasal
swab
perform
crosssect
studi
among
patient
seen
outpati
facil
mayo
clinic
rochest
mn
februari
april
patient
uri
symptom
case
prospect
enrol
use
conveni
sampl
sever
primari
care
set
includ
famili
medicin
clinic
commun
pediatr
clinic
express
care
walkin
clinic
provid
evalu
treatment
straightforward
common
condit
uri
patient
without
symptom
uri
within
week
prior
enrol
control
concurr
recruit
clinic
also
travel
medicin
clinic
enrol
similar
number
case
control
pediatr
year
adult
year
age
group
studyspecif
questionnair
use
collect
follow
inform
time
enrol
subject
age
sex
histori
asthma
presenc
chronic
medic
condit
diabet
kidney
diseas
liver
diseas
immunosuppress
condit
therapi
number
children
household
daycar
attend
pediatr
particip
andor
children
household
particip
smoke
exposur
case
inform
regard
date
symptom
onset
clinic
diagnosi
prescript
antivir
andor
antibacteri
therapi
current
ill
also
collect
control
inform
regard
respiratori
ill
last
month
includ
estim
date
last
symptom
obtain
two
upper
respiratori
specimen
nasal
throat
obtain
patient
studi
personnel
use
bd
diagnost
system
spark
md
usa
specimen
transport
virolog
laboratori
within
h
collect
place
refriger
specimen
extract
daili
test
perform
real
time
instead
specimen
batch
test
weekli
increas
effici
swab
broken
transport
remel
thermo
fisher
scientif
lenexa
ks
usa
prior
extract
use
magna
pure
compact
instrument
magna
pure
compact
total
nucleic
acid
isol
kitsmal
volum
cat
roch
appli
scienc
indianapoli
usa
nasal
throat
swab
particip
test
eragen
multicodeplx
respiratori
viru
panel
use
manufactur
recommend
assay
util
open
system
follow
rnadna
amplif
amplicon
transfer
luminex
instrument
specif
viru
detect
throat
swab
also
test
ga
separ
previous
valid
lightcyclerbas
realtim
pcr
assay
sensit
ga
detect
uhl
et
al
estim
respiratori
viru
detect
rate
among
case
among
asymptomat
control
sampl
size
requir
alpha
power
would
case
similar
number
control
primari
outcom
twobytwo
conting
tabl
creat
data
analyz
use
chisquar
test
differ
proport
interest
agreement
result
nasal
throat
swab
calcul
percentag
particip
either
test
posit
viru
test
neg
specimen
studi
approv
mayo
clinic
institut
review
board
inform
consent
assent
applic
obtain
particip
result
studi
report
provid
influenc
treatment
eightyon
particip
compris
case
adult
pediatr
control
adult
pediatr
enrol
februari
april
median
age
age
rang
year
adult
year
children
signific
differ
case
control
age
sex
histori
asthma
number
children
household
proport
children
attend
daycar
tabl
particip
underli
chronic
medic
ill
asthma
immunosuppress
condit
tabl
clinic
diagnos
among
symptomat
patient
includ
pharyng
tonsillopharyng
influenzalik
ill
uri
otherwis
specifi
cough
ill
bronchiti
sinus
averag
total
test
time
extract
result
multicodeplx
respiratori
viru
panel
h
overal
detect
rate
case
use
multicodeplx
respiratori
viru
panel
specimen
ie
proport
patient
uri
symptom
viru
detect
either
throat
nasal
swab
contrast
detect
rate
asymptomat
control
p
b
tabl
among
case
detect
rate
somewhat
greater
pediatr
adult
particip
although
differ
statist
signific
tabl
control
one
virus
detect
assay
pediatr
age
group
tabl
clinic
symptom
refer
standard
presenc
uri
clinic
specif
assay
proport
control
neg
test
result
overal
clinic
specif
among
adult
among
children
virus
detect
case
follow
influenza
n
influenza
b
n
rhinoviru
n
coronaviru
n
rsv
n
parainfluenza
n
adenoviru
b
n
adenoviru
e
n
type
frequenc
differ
virus
detect
studi
popul
differ
adult
children
fig
influenza
influenza
b
coronaviru
virus
detect
adult
greater
varieti
virus
observ
pediatr
subject
rhinoviru
frequent
characterist
pediatr
control
virus
detect
absenc
symptom
follow
adenoviru
c
detect
throat
subject
uri
symptom
week
prior
enrol
influenza
detect
throat
subject
histori
asthma
attend
daycar
young
children
subject
household
daycar
rhinoviru
detect
nose
throat
swab
young
children
household
daycar
ga
detect
case
control
p
overal
pathogen
either
viru
ga
identifi
case
viral
infect
alon
subject
differ
virus
rhinoviru
adenoviru
ga
infect
alon
coinfect
respiratori
viru
ga
ga
commonli
detect
among
case
diagnosi
pharyng
compar
differ
type
uri
although
differ
statist
signific
overal
agreement
result
nasal
throat
swab
either
viru
detect
specimen
specimen
neg
case
adult
children
control
adult
children
instanc
detect
differ
virus
specimen
particip
among
case
adult
children
specimen
throat
nasal
test
posit
use
multicodeplx
respiratori
viru
panel
combin
result
specimen
increas
detect
rate
overal
among
adult
case
among
pediatr
case
number
small
allow
evalu
specif
associ
type
viru
type
specimen
type
clinic
syndrom
type
specimen
yield
posit
assay
case
durat
symptom
could
determin
patient
posit
result
neg
result
use
multicodeplx
respiratori
viru
panel
mean
median
durat
symptom
prior
specimen
collect
day
rang
day
respect
detect
rate
among
case
durat
symptom
day
less
compar
among
durat
symptom
day
howev
statist
signific
case
symptom
uri
receiv
antibiot
therapi
among
receiv
antibiot
posit
ga
posit
viru
pathogen
could
identifi
remain
case
studi
use
multiplex
pcr
sampl
site
nasal
throat
swab
abl
detect
respiratori
virus
particip
upper
respiratori
infect
uri
detect
rate
consist
observ
studi
util
similar
diagnost
platform
brittainlong
et
al
although
viral
cultur
perform
direct
comparison
studi
detect
rate
higher
report
viral
cultur
previou
publish
studi
compar
multiplex
pcr
viral
cultur
aren
et
al
lee
et
al
clinic
symptom
refer
standard
presenc
uri
assay
demonstr
high
clinic
specif
particularli
among
adult
detect
rhinoviru
influenza
tabl
detect
virus
group
streptococcu
upper
respiratori
infect
age
group
type
specimen
control
p
valu
chisquar
particip
n
n
viru
detect
nasal
swab
viru
detect
throat
swab
viru
detect
either
specimen
ga
b
detect
pcr
throat
swab
adult
particip
n
n
viru
detect
nasal
swab
viru
detect
throat
swab
viru
detect
either
specimen
ga
b
detect
pcr
throat
swab
pediatr
particip
n
n
viru
detect
nasal
swab
viru
detect
throat
swab
viru
detect
either
specimen
ga
b
detect
pcr
throat
swab
one
nasal
swab
miss
b
ga
group
streptococcu
adenoviru
c
asymptomat
children
studi
despit
studi
conduct
influenza
season
influenza
virus
predominantli
recov
virus
symptomat
adult
influenza
virus
detect
adult
absenc
symptom
phenomenon
increas
viral
detect
among
asymptomat
individu
use
sensit
pcr
assay
previous
demonstr
rate
nonspecif
detect
use
multicod
plx
assay
studi
lower
rang
previous
publish
rate
use
similar
platform
brittainlong
et
al
buecher
et
al
fri
et
al
graat
et
al
sato
et
al
wright
et
al
contrast
virus
recov
cell
cultur
associ
ill
patient
asymptomat
individu
habl
et
al
data
clinic
specif
complementari
data
microbiolog
specif
assay
compar
viral
cultur
help
clinician
interpret
result
assay
outpati
practic
studi
rhinovirus
appear
frequent
detect
virus
asymptomat
person
sever
studi
use
molecular
assay
brittainlong
et
al
buecher
et
al
graat
et
al
jansen
et
al
data
also
consist
previou
observ
asymptomat
carriag
respiratori
virus
occur
frequent
children
adult
buecher
et
al
fri
et
al
instanc
detect
could
due
individu
convalesc
phase
acut
illnesseg
studi
investig
abl
detect
virus
nasopharynx
children
long
week
acut
infect
jartti
et
al
care
exclud
individu
respiratori
ill
within
week
prior
enrol
howev
small
sampl
size
specif
risk
factor
asymptomat
carriag
could
determin
studi
lastli
higher
rhinoviru
viral
load
use
molecular
assay
recent
shown
like
associ
clinic
symptom
author
suggest
defin
cutoff
valu
consid
molecular
test
use
diagnosi
respiratori
viral
infect
jansen
et
al
ideal
sampl
method
detect
respiratori
virus
respiratori
infect
use
multiplex
pcr
establish
studi
add
limit
publish
data
suggest
might
increas
diagnost
yield
use
differ
sampl
site
lieberman
et
al
first
demonstr
sampl
outpati
present
symptom
uri
find
particularli
notabl
adult
possibl
relat
smaller
quantiti
viru
shed
adult
compar
children
et
al
sampl
site
neither
feasibl
necessari
everi
patient
import
clinician
understand
limit
sampl
site
pursu
addit
site
clinic
situat
indic
futur
studi
aim
investig
whether
one
site
better
specif
viru
clinic
syndrom
stage
ill
potenti
benefit
sensit
specif
rapid
diagnost
assay
commun
viral
infect
guid
appropri
antibiot
therapi
studi
case
symptom
uri
prescrib
antibiot
howev
least
third
case
antibiot
therapi
provid
viral
uri
indic
routin
use
assay
potenti
curtail
inappropri
antimicrobi
therapi
hand
coinfect
ga
found
symptomat
case
furthermor
clinic
suspicion
ga
lead
either
test
treatment
occur
patient
would
suggest
test
strategi
combin
use
rapid
ga
test
rapid
viral
diagnost
might
necessari
optim
manag
outpati
uri
abl
identifi
etiolog
uri
approx
patient
combin
test
main
limit
studi
small
number
particip
preclud
evalu
associ
detect
specif
virus
specimen
type
present
clinic
syndrom
second
perform
direct
cultur
comparison
third
studi
limit
conveni
sampl
outpati
unabl
enrol
pediatr
particip
younger
year
elderli
patient
studi
perform
winterspr
season
howev
believ
import
evalu
clinic
specif
assay
season
preval
circul
respiratori
viral
pathogen
high
nonspecif
detect
might
potenti
increas
use
studi
sinc
use
nasal
flock
swab
improv
sensit
detect
respiratori
virus
demonstr
combin
nasal
throat
swab
may
requir
abudiab
et
al
despit
sever
avail
multiplex
assay
routin
use
clinic
set
particularli
ambulatori
clinic
still
limit
cost
need
batch
test
prolong
turnaround
time
access
lastli
although
direct
find
studi
import
disadvantag
open
system
assay
note
laboratori
higher
risk
crosssampl
contamin
compar
close
realtim
pcr
system
conclus
studi
provid
preliminari
data
issu
need
address
consid
routin
clinic
applic
multiplex
respiratori
viral
diagnost
assay
outpati
set
